These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24704154)

  • 1. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
    Eberle VA; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
    Eur J Pharm Sci; 2014 Jul; 58():34-43. PubMed ID: 24704154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets.
    Eberle VA; Häring A; Schoelkopf J; Gane PA; Huwyler J; Puchkov M
    Drug Dev Ind Pharm; 2016; 42(5):808-17. PubMed ID: 26307090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
    Reddy AB; Reddy ND
    Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.
    Eisenächer F; Garbacz G; Mäder K
    Eur J Pharm Biopharm; 2014 Nov; 88(3):778-86. PubMed ID: 25086221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swelling/floating capability and drug release characterizations of gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose.
    Chen YC; Ho HO; Liu DZ; Siow WS; Sheu MT
    PLoS One; 2015; 10(1):e0116914. PubMed ID: 25617891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
    Guguloth M; Bomma R; Veerabrahma K
    PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
    Liu Q; Fassihi R
    J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the physiological variability of fasted gastric pH and tablet retention time on the variability of in vitro dissolution and simulated plasma profiles.
    Kovačič NN; Pišlar M; Ilić I; Mrhar A; Bogataj M
    Int J Pharm; 2014 Oct; 473(1-2):552-9. PubMed ID: 25064726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of water-soluble polymers on the in vitro performance of floating mucoadhesive tablets containing metformin.
    Rajab M; Jouma M; Neubert RH; Dittgen M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):879-85. PubMed ID: 23607725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
    Bandari S; Eaga CM; Thadishetty A; Yamsani MR
    Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
    Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDSolver Software Application for Quantitative Analysis of In vitro Drug Release Behavior of the Gastroretentive Floating Tablets Combined with Radiological Study in Rabbits.
    Abdul Rasool BK; Sammour R
    Curr Drug Deliv; 2022 Aug; 19(9):949-965. PubMed ID: 35249487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical characterizations and sustained release profiling of gastroretentive drug delivery systems with improved floating and swelling capabilities.
    Chen YC; Ho HO; Lee TY; Sheu MT
    Int J Pharm; 2013 Jan; 441(1-2):162-9. PubMed ID: 23237874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®.
    Omachi Y
    AAPS PharmSciTech; 2022 Jun; 23(5):157. PubMed ID: 35672486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril floating and/or bioadhesive tablets: design and release kinetics.
    Nur AO; Zhang JS
    Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.